BridgeBio Inc. is seeking a Skeletal Dysplasia Account Manager to drive the launch of Infigratinib for achondroplasia. You will lead territory strategy, partner with multidisciplinary teams, and engage providers and families to advance patient care.
You will leverage clinical acumen to educate stakeholders and build advocacy, while collaborating with regional leadership and cross-functional partners in a dynamic, compliant environment. Travel will be extensive within the Northeast region.
#J-18808-LjbffrRemote Skeletal Dysplasia Launch Account Manager in washington at Unknown Company
This position is listed as full time and onsite.